The aim of the association is to develop effective, easy-to-take and affordable treatments to stop the progression of neurodegenerative diseases, such as Parkinson’s disease or Alzheimer’s disease among others. At present, the treatments available for these diseases are not effective in changing the course of the disease. We want to propose a different way to develop medicines by focusing on the effectiveness of treatment for each patient.
The scientific rationale: The mechanism identified to slow the accumulation of dead neurons involves a known receptor with described activation and inhibition pathways. In neurons, activation of this receptor induces …
Preliminary results: To confirm that this receptor is involved in the programmed death of neurons, our principal scientific investigator Emilie, funded an experiment on transgenic mice where the receptor is …
The development plan: Once a candidate is identified, the pre-clinical optimization phase of the candidate will be initiated before proceeding to any trials in humans. This pre-clinical phase, which includes …
We have had initial funding but more is needed, please donate to contribute to a potentially revolutionary treatment for neurodegenerative disorders. Make a donation.
The Institut Jacques Armand association is a non-profit association, governed by the 1901 law, created in 2021 by: Michaël Déjean (president), Bernadette Déjean (treasurer), Delphine Déjean (secretary) and Emilie Déjean (honorary member).
Do you want to stay up to date with the latest news? Then scroll down and register on our mailing list. After registration, you will automatically receive notification of new messages by email.
A recent podcast from Parkinson’s foundation based in the US summarizes the new exercise recommendations for patients living with Parkinson’s disease: https://www.parkinson.org/Living-with-Parkinsons/Resources-and-Support/Podcast Have a good time!
